[HTML][HTML] The lingering mysteries of metastatic recurrence in breast cancer
Despite being the hallmark of cancer that is responsible for the highest number of deaths,
very little is known about the biology of metastasis. Metastatic disease typically manifests …
very little is known about the biology of metastasis. Metastatic disease typically manifests …
The impact of mastectomy on Iranian women sexuality and body image: a systematic review of qualitative studies
Purpose Mastectomy in women is perceived as losing feminine identity and reducing sexual
attraction. The aim of this review is to explore the perception and impacts of mastectomy on …
attraction. The aim of this review is to explore the perception and impacts of mastectomy on …
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
EL Mayer, AC Dueck, M Martin, G Rubovszky… - The lancet …, 2021 - thelancet.com
Background Palbociclib added to endocrine therapy improves progression-free survival in
hormone-receptor-positive, HER2-negative, metastatic breast cancer. The PALLAS trial …
hormone-receptor-positive, HER2-negative, metastatic breast cancer. The PALLAS trial …
[HTML][HTML] Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy
JA Hansen, M Naghavi-Behzad, O Gerke, C Baun… - PLoS …, 2021 - journals.plos.org
We compared lesion-based sensitivity of dual-time-point FDG-PET/CT, bone scintigraphy
(BS), and low-dose CT (LDCT) for detection of various types of bone metastases in patients …
(BS), and low-dose CT (LDCT) for detection of various types of bone metastases in patients …
Imaging surveillance of breast cancer survivors with digital mammography versus digital breast tomosynthesis
M Bahl, S Mercaldo, AM McCarthy, CD Lehman - Radiology, 2021 - pubs.rsna.org
Background Among breast cancer survivors, detecting a breast cancer when it is
asymptomatic (rather than symptomatic) improves survival; thus, imaging surveillance in …
asymptomatic (rather than symptomatic) improves survival; thus, imaging surveillance in …
[HTML][HTML] Deep learning-based prediction model for breast cancer recurrence using adjuvant breast cancer cohort in tertiary cancer center registry
JY Kim, YS Lee, J Yu, Y Park, SK Lee, M Lee… - Frontiers in …, 2021 - frontiersin.org
Several prognosis prediction models have been developed for breast cancer (BC) patients
with curative surgery, but there is still an unmet need to precisely determine BC prognosis …
with curative surgery, but there is still an unmet need to precisely determine BC prognosis …
[HTML][HTML] The emerging role of circulating tumor DNA in the management of breast cancer
Simple Summary As breast cancer diagnoses continue to rise among women worldwide, it is
important to explore and improve upon methods of diagnosis and surveillance. Liquid …
important to explore and improve upon methods of diagnosis and surveillance. Liquid …
A pilot randomized trial of an educational intervention to increase genetic counseling and genetic testing among Latina breast cancer survivors
CC Conley, EM Castro‐Figueroa… - Journal of genetic …, 2021 - Wiley Online Library
Latinas are less likely to participate in genetic counseling (GC) and genetic testing (GT) than
non‐Hispanic Whites. A multisite, randomized pilot study tested a culturally targeted …
non‐Hispanic Whites. A multisite, randomized pilot study tested a culturally targeted …
[HTML][HTML] Cisplatin+/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer
Patients with triple-negative breast cancer (TNBC) who have residual disease after
neoadjuvant therapy have a high risk of recurrence. We tested the impact of DNA-damaging …
neoadjuvant therapy have a high risk of recurrence. We tested the impact of DNA-damaging …
[HTML][HTML] Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3
Background Most current guidelines do not recommend the serial analysis of tumour marker
CA 15.3 in the follow-up of asymptomatic patients treated for early breast cancer (EBC) …
CA 15.3 in the follow-up of asymptomatic patients treated for early breast cancer (EBC) …